Mark McClung
Keine laufenden Positionen mehr
Vermögen: 56 033 $ am 30.04.2024
Profil
Mark D.
McClung worked as the VP & General Manager-Global Oncology Commercial at Amgen, Inc. from 2015 to 2019.
He also worked as the Chief Commercial Officer & Senior Vice President at Onyx Pharmaceuticals, Inc. He is currently the Chief Operating Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2020 to 2024.
McClung completed his undergraduate degree from York University and the University of Guelph.
He also completed an undergraduate degree from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.11.2023 | 111 397 ( 0,05% ) | 56 033 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Mark McClung
| Unternehmen | Position | Ende |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Geschäftsführer | 02.01.2024 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2019 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Ausbildung von Mark McClung
| University of Guelph | Undergraduate Degree |
| York University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
